Complement Component 1, Q Subcomponent-Like 3 (C1QL3) (Middle Region) Peptide
-
- Target See all C1QL3 products
- C1QL3 (Complement Component 1, Q Subcomponent-Like 3 (C1QL3))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- VPKIAFYAGL KRQHEGYEVL KFDDVVTNLG NHYDPTTGKF TCSIPGIYFF
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-C1QL3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- C1QL3 (Complement Component 1, Q Subcomponent-Like 3 (C1QL3))
- Synonyms
- 1110065A22Rik Peptide, AI661623 Peptide, C1ql Peptide, C1qtnf13 Peptide, CTRP13 Peptide, K100 Peptide, C1QTNF13 Peptide, zgc:77412 Peptide, C1q-like 3 Peptide, complement C1q like 3 Peptide, complement component 1, q subcomponent-like 3b Peptide, C1ql3 Peptide, C1QL3 Peptide, c1ql3b Peptide
- Background
-
C1QL3 may regulate the number of excitatory synapses that are formed on hippocampus neurons. It has no effect on inhibitory synapses . It plays a role in glucose homeostasis. Via AMPK signaling pathway, C1QL3 stimulates glucose uptake in adipocytes, myotubes and hepatocytes and enhances insulin-stimulated glucose uptake. In a hepatoma cell line, C1QL3 reduces the expression of gluconeogenic enzymes G6PC and PCK1 and hence decreases de novo glucose production.
Alias Symbols: C1QL3,CTRP13,
Protein Size: 255 - Gene ID
- 389941
- NCBI Accession
- NP_001010908
- UniProt
- Q5VWW1
-